| [1] |
Gajdos C, Tartter PI, Bleiweiss IJ, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics[J]. Ann Surg, 2002, 235(2): 246-251.
|
| [2] |
Bent CK, Bassett LW, D'Orsi CJ, et al. The positive predictive value of BI-RADS mi-crocalcification descriptors and final as?sessment categories[J]. Am J Roentgenol, 2010, 194(5): 1378-1383.
|
| [3] |
Sickles EA, D'Orsi CJ, Bassett LW, et al. ACR BI-RADS Atlas (breast imaging reporting and data system) [M]. Reston:American College of Radiology, 2013: 61-78, 135-138.
|
| [4] |
Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates[J]. Radiology, 2001, 218(2): 497-502.
|
| [5] |
邹如海，韩峰，曹云, 等. 超声引导乳腺肿物穿刺活检导致病理组织学诊断低估的原因分析[J]. 中华医学超声杂志(电子版), 2010, 7(1): 60-65.
|
| [6] |
石剑，魏建南，曾圣光,等. ATEC活检系统在乳腺钙化灶立体定位活检中的应用[J]. 中国微创外科杂志, 2020, 20(10): 865-870.
|
| [7] |
Penco S, Rizzo S, Bozzini A C, et al. Stereotactic vacuum-assisted breast biopsy is not a therapeutic procedure even when all mammographically found calcifications are removed: analysis of 4,086 procedures[J]. Ajr Am J Roentgenol, 2010, 195(5): 1255-1260.
|
| [8] |
Park H L, Hong J. Vacuum-assisted breast biopsy for breast cancer[J]. Gland Surgery, 2014, 3(2): 120-127.
|
| [9] |
Safioleas P M, Koulocheri D, Michalopoulos N, et al. The value of stereotactic vacuum assisted breast biopsy in the investigation of microcalcifications. A six-year experience with 853 patients[J]. J BUON, 2017, 22(2): 340-346.
|
| [10] |
Shozo O, Shigemitsu T, Kenjiro A, et al. Breast biopsy for mammographically detected non-palpable lesions using a vacuum-assisted biopsy device (mammotome) and an upright-type stereotactic mammography unit[J]. Jpn J Cli Oncol, 2001, 31(11): 527-531.
|
| [11] |
Renshaw AA, Gould EW. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies[J]. Pathology, 2016, 48(1): 25-29.
|
| [12] |
Latronico A, Nicosia L, Faggian A, et al. Atypical ductal hyperplasia: our experience in the management and long term clinical follow-up in 71 patients[J]. Breast, 2018, 37(2): 1-5.
|
| [13] |
Youn I, Kim M J, Moon H J, et al. Absence of residual microcalcifications in atypical ductal hyperplasia diagnosed via stereotactic vacuum-assisted breast biopsy: is surgical excision obviated?[J]. J Breast Cancer, 2014, 17(3): 265-269.
|
| [14] |
Esen G, T utar B, Uras C, et al. Vacuum-assisted stereotactic breast biopsy in the diagnosis and management of suspicious microcalcifications[J]. Diagn Interv Radiol, 2016, 22(4): 326-333.
|
| [15] |
Rageth CJ, Rubenov R, Bronz C, et al. Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens[J]. Breast Cancer, 2019, 26(4): 452-458.
|
| [16] |
Chang SLQ, Huang ML, Leung JWT, et al. Malignancy rates of stereotactic biopsies of two or more distinct sites of suspicious calcifications in women without known breast cancer[J]. Clinical Imaging, 2019, 58: 156-160.
|
| [17] |
Raj SD, Sedgwick EL, Severs FJ, et al. Stereotactic biopsy of segmental breast calcifications: is sampling of anterior and posterior components necessary?[J]. Acad Radiol, 2016, 23(6): 682-686.
|
| [18] |
Li S, Qu F, Yang Y, et al. Value of stereotactic 11-gauge vacuum-assisted breast biopsy in non-palpable suspicious calcifications: an eight-year single institution experience with 587 patients[J]. Gland Surgery, 2020, 9(5): 1258-1266.
|